×

IL1RL-1 as a cardiovascular disease marker and therapeutic target

  • US 7,655,415 B2
  • Filed: 05/26/2006
  • Issued: 02/02/2010
  • Est. Priority Date: 05/09/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A method, comprising:

  • determining the level of an IL1RL-1 molecule in a sample from a subject having or suspected of having a cardiovascular condition by contacting the sample with an agent, wherein the agent specifically binds to the IL1RL-1 molecule, anddetermining the level of at least one other marker in the sample that is predictive of outcome after a myocardial infarction or is increased in heart failure.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×